New #HCV black box warning for #HBV reactivation affects #harvoni #epclusa #viekira #zepatier #daklinza #sovaldi #olysio #technivie

New #daklinza label explicitly includes cirrhosis child B & C and recommends #daklinza #sofosbuvir and #ribavirin for 12 wks for #HCV GT1-3

FDA expands #daklinza label with #sovaldi to #HCV GT1-3 incl. post-transplant, #HIV co-infection & cirrhosis #$BMY http://www.streetinsider.com/dr/news.php?id=11284730

@regulusRx initiated #HCV phase 2 studies for RG-101 in combination with #harvoni #daklinza and #olysio with interim data by end of year

#daklinza #sovaldi combo +/- ribavirin in #AASLD/#IDSA guidelines for #HCV GT1-3 rx naive and experienced patients based on ALLY studies

HCV Combo Effective in Real World Compassionate use program saw high cure rates in HIV/HCV ...

#HCV combo of #sovaldi and #daklinza effective in Real World experience for #HIV co infected http://www.medpagetoday.com/MeetingCoverage/IAS/52751

#daklinza + #sovaldi for 12 wks is IFN/RBV free for #HCV GT3 non cirrhotics. Limitations of Use statement for SVR reduction in cirrhotics

Page Not Found | FDA

# FDA approves #daclatasvir as new treatment for chronic #HCV genotype 3 #daklinza

www.fda.gov/NewsEvents/Newsroom/Pres...

#BMS news don't change status of #Sunvepra/#Daklinza combo approved in Japan for #HCV GT1b and #daclatasvir in EU as combo with other drugs

Bristol-Myers Squibb launches Daklinza in the UK for chro... US drug major Bristol-Myers Squibb has launched Daklinza ...

BMS launches #Daklinza (daclatasvir) in the UK for HCV. It will be very interesting to monitor early patterns of use. www.thepharmaletter.com/article/bristol-myers-sq...